SCHEMBL6230409

SCHEMBL6230409

O=C(O)c1cccc2c(Br)csc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRNP P04156 1/20 0.49
NR4A1 P22736 1/20 0.46
NR4A2 P43354 1/20 0.46
NR4A3 Q92570 1/20 0.46
ALDH1A1 P00352 3/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 2/20 0.41
CDC25B P30305 1/20 0.41
GPR35 Q9HC97 3/20 0.40
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
TBXAS1 P24557 1/20 0.39
KDM4E B2RXH2 2/20 0.37
FABP4 P15090 1/20 0.37
AKR1C3 P42330 1/20 0.37
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
HMGB1 P09429 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11660115 0.85 TBXAS1 (0.50) PRNPNR4A1NR4A2NR4A3ALDH1A1
SCHEMBL1476135 0.84 ALDH1A1 (0.40) PRNPALDH1A1ALOX15TSHRKMT2A
SCHEMBL6232575 0.81 NR4A1 (0.46) PRNPNR4A1NR4A2NR4A3ALDH1A1
SCHEMBL6130740 0.80 PRNP (0.47) PRNPNR4A1NR4A2NR4A3ALDH1A1
SCHEMBL6234251 0.80 ALDH1A1 (0.47) PRNPNR4A1NR4A2NR4A3ALDH1A1
SCHEMBL10550955 0.77 HNF4A (0.50) NR4A1NR4A2NR4A3ALDH1A1ALOX15
SCHEMBL6305533 0.77 CLCN2 (0.43) NR4A1NR4A2NR4A3ALDH1A1ALOX15
SCHEMBL6235442 0.76 CDC25B (0.48) NR4A1NR4A2NR4A3ALDH1A1TSHR
SCHEMBL6234160 0.76 POLB (0.43) NR4A1NR4A2NR4A3ALDH1A1ALOX15
SCHEMBL6229996 0.76 NR4A1 (0.41) PRNPNR4A1NR4A2NR4A3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250059220-A1 SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AND METHODS OF USE THEREOF MERCK SHARP & DOHME LLC (US) 2025-02-20 US disclosed
WO-2023121939-A1 SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AND METHODS OF USE THEREOF MERCK SHARP & DOHME LLC (US) 2023-06-29 WO disclosed
WO-2023121939-A1 SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AND METHODS OF USE THEREOF MERCK SHARP & DOHME LLC (US) 2023-06-29 WO disclosed
EP-0945450-B1 FUSED HETEROCYCLIC BENZENECARBOXYLIC ACID AMIDE DERIVATIVES AND PGD2 ANTAGONISTS CONTAINING THE SAME SHIONOGI & CO (JP) 2005-05-11 EP disclosed
US-6069166-A INHIBITORY ACTIVITY AGAINST INFILTRATION OF EOSIONOPHILS, AND ARE USEFUL AS DRUGS FOR TREATING NASAL BLOCKAGE SHIONOGI & CO., LTD. (JP) 2000-05-30 US disclosed
EP-0945450-A1 FUSED HETEROCYCLIC BENZENECARBOXYLIC ACID AMIDE DERIVATIVES AND PGD2 ANTAGONISTS CONTAINING THE SAME SHIONOGI & CO., LTD. (JP) 1999-09-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250059220-A1 SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AND METHODS OF USE THEREOF SULT1E1, TPMT, SULT1A1 PRNP 3275/4885NR4A1 526/4885NR4A2 580/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.